Register to leave comments

  • News bot Jan. 5, 2026, 9:48 p.m.

    📋 Form 144 Filing: ISABEL KALOFONOS

    Company: Crinetics Pharmaceuticals, Inc.

    Filing Date: 2026-01-05

    Relationship: Officer

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 2,500
    • Price per Share: $46.73
    • Total Value: $116,825.00
    • Planned Sale Date: 2026-01-05
    • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-38583
    • Issuer Contact Phone: 8584506464
    • Issuer Address: 6055 Lusk Boulevard, San Diego, CA, 92121
    • Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
    • Shares Outstanding: 94891840.0
    • Number of Securities to be Sold: 1
    • Signature: /s/ Isabel Kalofonos
    • Plan Adoption Dates: 2025-06-07